VENCF (Vencanna Ventures) YoY EBITDA Growth: 85.71% (As of Jan. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Vencanna Ventures YoY EBITDA Growth?

Vencanna Ventures VENCF YoY EBITDA Growth is 85.71% as of Jan. 2026. The stock has 4 warning signs investors should review.

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Vencanna Ventures's YoY EBITDA Growth for the quarter that ended in Jan. 2026 was 85.71%.

Vencanna Ventures's EBITDA per Share for the three months ended in Jan. 2026 was $-0.00.

Vencanna Ventures YoY EBITDA Growth Historical Data

* Premium members only.

The historical data trend for Vencanna Ventures's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Vencanna Ventures YoY EBITDA Growth Chart

Vencanna Ventures Annual Data
Trend Apr16 Apr17 Apr18 Apr19 Apr20 Apr21 Apr22 Apr23 Apr24 Apr25
YoY EBITDA Growth
Get a 7-Day Free Trial Premium Member Only Premium Member Only -400.00 66.67 -50.00 33.33 -600.00

Vencanna Ventures Quarterly Data
Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25 Apr25 Jul25 Oct25 Jan26
YoY EBITDA Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -600.00 0.00 -50.00 0.00 85.71

Vencanna Ventures YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Vencanna Ventures's YoY EBITDA Growth for the fiscal year that ended in Apr. 2025 is calculated as:

YoY EBITDA Growth (A: Apr. 2025 )
=(EBITDA per Share (A: Apr. 2025 )-EBITDA per Share (A: Apr. 2024 ))/ | EBITDA per Share (A: Apr. 2024 ) |
=(-0.014--0.002)/ | -0.002 |
=-600.00 %

Vencanna Ventures's YoY EBITDA Growth for the quarter that ended in Jan. 2026 is calculated as:

YoY EBITDA Growth (Q: Jan. 2026 )
=(EBITDA per Share (Q: Jan. 2026 )-EBITDA per Share (Q: Jan. 2025 )) / | EBITDA per Share (Q: Jan. 2025 )) |
=(-0.001--0.007)/ | -0.007 |
=85.71 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about YoY EBITDA Growth →
What does a YoY EBITDA Growth of 85.71% mean?
Vencanna Ventures (VENCF) has a YoY EBITDA Growth of 85.71% as of Jan. 2026. YoY EBITDA Growth is the percentage change of EBITDA per share over the past 12-month. View historical data for Vencanna Ventures and its competitors.
Is Vencanna Ventures' YoY EBITDA Growth too high?
Vencanna Ventures' current YoY EBITDA Growth is 85.71%.
How does Vencanna Ventures' YoY EBITDA Growth compare to ZTS?
Vencanna Ventures' YoY EBITDA Growth of 85.71% can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good YoY EBITDA Growth for a Drug Manufacturers company?
A good YoY EBITDA Growth depends on the Drug Manufacturers industry context. However, YoY EBITDA Growth should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high YoY EBITDA Growth mean?
A high YoY EBITDA Growth can signal that a stock is expensive relative to its fundamentals. YoY EBITDA Growth is the percentage change of EBITDA per share over the past 12-month. View historical data for Vencanna Ventures and its competitors. Vencanna Ventures's current YoY EBITDA Growth is 85.71%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vencanna Ventures stock overvalued right now?
Vencanna Ventures (VENCF) has a current YoY EBITDA Growth of 85.71%. The current YoY EBITDA Growth is 85.71%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is YoY EBITDA Growth calculated?
YoY EBITDA Growth is calculated from a company's financial statements. For Vencanna Ventures (VENCF), the current YoY EBITDA Growth is 85.71% as of Jan. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Vencanna Ventures Business Description

Other Exchanges VENI:Canada
Address 622 5th Avenue SW, Suite 200, Calgary, AB, CAN, T2P 0M6
Vencanna Ventures Inc aims to provide investors with a diversified, high-growth, cannabis investment plan through strategic investments and acquisitions focused throughout the value chain (cultivation, processing, and distribution), including ancillary businesses. The company generates the majority of its revenue from the United States.